Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Cerezyme
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 772
2018 Revenue in Millions : 775
Growth (%) : 0
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 835
2019 Revenue in Millions : 856
Growth (%) : -3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 752
2020 Revenue in Millions : 752
Growth (%) : -1
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 775
2021 Revenue in Millions : 752
Growth (%) : 3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 741
2022 Revenue in Millions : 775
Growth (%) : -3
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2014 Revenue in Millions : 3.90%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Disease
Currency : USD
2015 Revenue in Millions : 787
2014 Revenue in Millions : 833
Growth (%) : 6%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 793
2015 Revenue in Millions : 802
Growth (%) : -1
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 905
2016 Revenue in Millions : 928
Growth (%) : -2
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2018 Revenue in Millions : 803
2017 Revenue in Millions : 825
Growth (%) : -3%
LOOKING FOR A SUPPLIER?